Basic information Safety Supplier Related

MRS 1706

Basic information Safety Supplier Related

MRS 1706 Basic information

Product Name:
MRS 1706
Synonyms:
  • MRS-1706;MRS 1706;MRS1706
  • N-(4-ACETYLPHENYL)-2-[4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H-PURIN-8-YL)PHENOXY]ACETAMIDE
  • MRS 1706
  • N-(4-acetylphenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
  • Acetamide, N-(4-acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
  • N-(4-Acetylphenyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamide
  • MRS-1706,cAMP,P1 receptor,corpus cavernosal strips,duration,inhibit,MRS 1706,Adenosine Receptor,MRS1706,Inhibitor,adenosine,magnitude
  • MRS-1706, 10 mM in DMSO
CAS:
264622-53-9
MF:
C27H29N5O5
MW:
503.55
Mol File:
264622-53-9.mol
More
Less

MRS 1706 Chemical Properties

Density 
1.293±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,2-8°C
solubility 
DMSO : 6.4 mg/mL (12.71 mM; Need ultrasonic and warming)H2O : < 0.1 mg/mL (insoluble)
form 
Powder
pka
8.25±0.70(Predicted)
color 
Off-white to yellow
More
Less

MRS 1706 Usage And Synthesis

Description

MRS1706 is a selective adenosine A2B receptor inverse agonist with Ki values of 1.39, 157, 112, and 230 nM for human A2B, A1, A2A, and A3 receptors, respectively.

Uses

MRS 1706 is a selective and potent Adenosine A2B-R inverse agonist Ki (binding affinity) values of 1.39, 157, 112, and 230 nM for human A2B, A1, A2A, and A3 receptors, respectively.

Biological Activity

Potent and selective adenosine A 2B receptor inverse agonist (K i values are 1.39, 157, 112 and 230 nM for human A 2B , A 1 , A 2A and A 3 receptors respectively).

in vivo

MRS-1706 (1-10 μM; intracavernous injection; Ada–/– mice) reduces the magnitude and duration of electrical field stimulation (EFS)-induced contraction of corpus cavernosal strips (CCSs) from sickle cell disease (SCD) transgenic mice and inhibits the level of cAMP[2].

Animal Model:Ada–/– mice[2]
Dosage:1 and 10 μM
Administration:Intracavernous injection
Result:Inhibited A2BR signaling and reduced the magnitude and duration.
Inhibited the level of cAMP.

References

[1] YONG-CHUL KIM. Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A2B Adenosine Receptors[J]. Journal of Medicinal Chemistry, 2000, 43 6: 1165-1172. DOI: 10.1021/jm990421v
[2] QILAN LI. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 320 2: 637-645. DOI: 10.1124/jpet.106.111203

MRS 1706Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
MQ (shanghai) Pharmaceuticals Co., Ltd.
Tel
13761635123
Email
1014988033@qq.com
Aikon International Limited
Tel
025-58859352 18068836627
Email
dt3@aikonchem.com